Clinical Trial: Metformin in Parkinson's Disease: Safety and Efficacy

U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07806019) titled 'Metformin in Parkinson's Disease: Safety and Efficacy' on Aug. 20.

Brief Summary: This study will evaluate whether metformin when it will be given to patients with Parkinson's disease along with standard therapy (levodopa carbidopa) will improve motor symptoms and decreases levels of alpha synuclein and MDA in patients with PD as compare to PD patients receiving only standard therapy (levodopa carbidopa)

Study Start Date: Aug. 28

Study Type: INTERVENTIONAL

Condition: Parkinsons Disease (PD)

Intervention: DRUG: Metformin 500mg

Metformin will be given to the group B along with the standard treatment

Recruitment Status: NOT_YET...